Published Aug 08, 2018

Harbour BioMed inks $350 million deal for rights to A167

Member News

Related or similar articles

October 13, 2026

Biotech's Cathedral Problem: Rethinking Lab Space After the Boom

Discover the true cost of biotech lab space beyond rent and how shared labs help growing companies reduce overhead and scale more efficiently.
Blog Posts
May 6, 2025

How AI is Revolutionizing Biotech—and Why Labshares Remains the Ideal Home for Emerging Biotechs

AI is transforming biotech by accelerating drug discovery, diagnostics, and research. Emerging AI-biotech companies still need flexible wet lab space, advanced equipment, and experimental validation to bring discoveries to market.
Blog Posts
December 9, 2021

Bulfinch Leases 40,000 Square Feet to Labshares

The Bulfinch Companies, Inc. (Bulfinch), a commercial real estate and investment firm, and Labshares Newton today announced the expansion of the life science and biotech co-working shared lab space at Chapel Bridge Park.
Labshares News